Your browser is no longer supported. Please, upgrade your browser.
MYOS MYOS RENS Technology Inc. daily Stock Chart
MYOS [NASD]
MYOS RENS Technology Inc.
Index- P/E- EPS (ttm)-0.40 Insider Own24.90% Shs Outstand8.59M Perf Week11.94%
Market Cap14.69M Forward P/E- EPS next Y-0.51 Insider Trans10.63% Shs Float5.24M Perf Month25.30%
Income-3.00M PEG- EPS next Q-0.12 Inst Own5.00% Short Float2.66% Perf Quarter18.75%
Sales0.50M P/S29.38 EPS this Y-632.60% Inst Trans- Short Ratio3.68 Perf Half Y1.18%
Book/sh0.57 P/B3.00 EPS next Y-2.00% ROA-65.10% Target Price3.75 Perf Year24.28%
Cash/sh0.26 P/C6.68 EPS next 5Y- ROE-86.60% 52W Range1.04 - 2.02 Perf YTD20.42%
Dividend- P/FCF- EPS past 5Y25.20% ROI-84.30% 52W High-16.83% Beta0.81
Dividend %- Quick Ratio2.10 Sales past 5Y-35.90% Gross Margin38.10% 52W Low61.54% ATR0.13
Employees12 Current Ratio3.50 Sales Q/Q0.00% Oper. Margin- RSI (14)58.86 Volatility7.10% 8.51%
OptionableNo Debt/Eq0.18 EPS Q/Q31.80% Profit Margin- Rel Volume2.34 Prev Close1.71
ShortableYes LT Debt/Eq0.00 EarningsAug 07 AMC Payout- Avg Volume37.84K Price1.68
Recom- SMA205.25% SMA5020.59% SMA20018.74% Volume63,838 Change-1.75%
Jul-08-19 02:37PM  MYOS RENS Technology Congratulates the United States Women's National Soccer Team and Team Yolked® Member Carli Lloyd on Winning the 2019 FIFA Women's World Cup PR Newswire
Jun-27-19 06:46AM  Introducing MYOS RENS Technology (NASDAQ:MYOS), The Stock That Tanked 88% Simply Wall St. -10.59%
Jun-20-19 03:15PM  MYOS: UC Berkeley Study Results Should Help Open New, Large Market for Fortetropin Zacks Small Cap Research
Jun-18-19 06:09PM  MYOS RENS' Fortetropin® Shown to Increase the Rate of Muscle Protein Synthesis in Older Adults in Clinical Study Carried out at University of California, Berkeley PR Newswire
05:46PM  Edited Transcript of MYOS earnings conference call or presentation 9-May-19 3:00pm GMT Thomson Reuters StreetEvents
May-29-19 07:05AM  MYOS RENS Technology Announces Endorsement Partnership for Yolked® with Carli Lloyd, Two-Time Olympic Gold Medalist, FIFA Women's World Cup Champion, and Captain of the United States Women's National Soccer Team PR Newswire
May-23-19 10:10AM  MYOS: Q1 2019: MYOS Canine Sales Jump, Initial Reviews are Highly Encouraging. New QoL Dog Study Planned Zacks Small Cap Research
May-21-19 07:30AM  MYOS RENS Technology to Present at the 9th Annual LD Micro Invitational in Los Angeles, CA PR Newswire
May-08-19 06:00PM  MYOS RENS Technology Reports 161% Increase in Revenues, 238% Increase in Gross Profit in First Quarter 2019 PR Newswire
May-01-19 07:30AM  MYOS RENS Technology Announces the Date for the Release of First Quarter 2019 Results, Conference Call and Webcast PR Newswire
Apr-04-19 05:45AM  MYOS RENS Technology Signs Distribution Agreement with National Sales Associates, LLC PR Newswire +6.08%
Apr-02-19 10:00AM  MYOS: Yolked, MYOS Canine Formula Sales Accelerating. Going Into 2019 w/ New Clinical Evidence and Marketing Initiatives Zacks Small Cap Research
Mar-28-19 06:00AM  MYOS RENS Technology Reports Fourth Quarter and Fiscal 2018 Results PR Newswire +14.89%
Mar-27-19 09:15PM  Myos Rens Technology Inc (MYOS) CEO Joseph Mannello Bought $250,000 of Shares GuruFocus.com
Mar-26-19 07:30AM  MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Fiscal Year 2018 Results, Conference Call and Webcast PR Newswire
Feb-27-19 07:16AM  MYOS RENS Technology Announces Initiation of a Study at Kansas State University to Evaluate the Impact of Fortetropin® on Quality of Life and Activity in Geriatric Dogs PR Newswire
Feb-21-19 07:16AM  Should You Be Concerned About MYOS RENS Technology Inc.s (NASDAQ:MYOS) Historical Volatility? Simply Wall St.
Feb-19-19 08:25AM  Report: Exploring Fundamental Drivers Behind Crocs, Portola Pharmaceuticals, ANSYS, Alpha and Omega Semiconductor, PetMed Express, and MYOS RENS Technology New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-07-19 07:30AM  MYOS RENS Technology Announces First Endorsement Deal for Yolked® with NBA Superstar Aaron Gordon PR Newswire
Jan-24-19 01:25PM  MYOS: Positive Results of Canine Muscle Recovery Study Should Benefit Uptake, Inform Human Development Programs Zacks Small Cap Research
Jan-23-19 08:00AM  MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX PR Newswire
Jan-15-19 07:00AM  MYOS RENS Technology Announces Study Results Demonstrating Fortetropin®, the Active Ingredient in Myos Canine Muscle Formula, Prevents Muscle Loss in Canines After Surgery and Enhances Recovery PR Newswire +9.74%
Jan-08-19 06:05AM  MYOS RENS Technology Announces Upcoming Presentation of Results from a Kansas State University Study Evaluating the Impact of Fortetropin® on Canine Muscle Loss after Surgery, at a Major Veterinary Conference, January 20, 2019 PR Newswire +5.67%
Jan-03-19 06:05AM  MYOS RENS Technology Receives a New Patent from the United States Patent and Trademark Office PR Newswire
Dec-25-18 11:42AM  Have Insiders Been Buying MYOS RENS Technology Inc. (NASDAQ:MYOS) Shares? Simply Wall St.
Dec-14-18 06:05AM  MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders PR Newswire
Dec-13-18 04:05PM  MYOS RENS Technology Announces Results of Its 2018 Annual Meeting of Stockholders PR Newswire
Dec-12-18 06:50AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Corcept Therapeutics ACCESSWIRE -15.88%
Dec-11-18 12:11PM  Why MYOS Stock Is Skyrocketing Today InvestorPlace +55.96%
10:29AM  Myos Shares Find Nourishment From Vitamin Shoppe Distribution Deal Benzinga
06:05AM  MYOS RENS Technology Launches 'Yolked®', Its Sports Nutrition Product, With The Vitamin Shoppe® Nationwide PR Newswire
Dec-06-18 06:10AM  MYOS RENS Technology Announces Approval of $1.2 Million in NJEDA NOL Program Tax Credits PR Newswire +5.36%
Dec-04-18 03:30PM  MYOS: MYOS Canine Initial Sales and Add l Distribution. Yolked Feedback Positive. Medical Nutrition Could Be Compelling Growth Opportunity Zacks Small Cap Research
Nov-14-18 04:15PM  MYOS RENS Technology Reports Financial Results for the Third Quarter of 2018 and Business Updates PR Newswire -7.09%
Nov-08-18 06:10AM  MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula To 6,000+ Veterinary Hospitals PR Newswire
Nov-06-18 05:26PM  MYOS RENS Technology Announces The Date For The Release Of Third Quarter 2018 Results, Conference Call And Webcast PR Newswire +5.79%
Oct-16-18 08:20AM  Investor Expectations to Drive Momentum within Pacific Ethanol, CorVel, Surmodics, Alpha and Omega Semiconductor, MYOS RENS Technology, and Golden Entertainment Discovering Underlying Factors of Influence GlobeNewswire
Oct-02-18 06:10AM  Centers For Medicare and Medicaid Services Approves Reimbursement For Unique Fortetropin®-Based Enteral Nutrition Formula PR Newswire
Sep-26-18 07:00AM  MYOS RENS Technology To Exhibit MYOS Canine Muscle Formula At The Atlantic Coast Veterinary Conference, October 8-11, 2018 PR Newswire
Sep-11-18 11:20AM  Should You Have MYOS RENS Technology Incs (NASDAQ:MYOS) In Your Portfolio? Simply Wall St.
Aug-17-18 02:00PM  MYOS: Yolked Well-Received, MYOS Canine Formula Launched Zacks Small Cap Research
08:20AM  Consolidated Research: 2018 Summary Expectations for PDF Solutions, MYOS RENS Technology, Aldeyra Therapeutics, The Ensign Group, Everi, and Ardelyx Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-08-18 05:39PM  MYOS RENS Technology Reports 49% Increase In Net Revenues In Second Quarter Of 2018 PR Newswire
Aug-02-18 06:15AM  MYOS RENS Technology Announces The Date For The Release Of Second Quarter And First Half 2018 Results, Conference Call And Webcast PR Newswire -10.14%
Jul-12-18 08:00AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Canopy Growth ACCESSWIRE -25.38%
Jun-06-18 06:10AM  MYOS RENS Technology Launches Advanced Veterinary Supplement Product For Dogs, Powered By Fortetropin® PR Newswire
May-31-18 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum Corporation of China, Okta, and MYOS RENS Technology New Research Emphasizes Economic Growth GlobeNewswire -5.01%
May-24-18 10:11AM  Should You Buy MYOS RENS Technology Inc (NASDAQ:MYOS) Now? Simply Wall St.
May-16-18 09:45AM  MYOS: Several Development-Related Milestones Upcoming Zacks Small Cap Research
May-09-18 05:36PM  MYOS RENS Technology Reports First Quarter Financial Results PR Newswire +13.14%
May-03-18 08:02PM  /C O R R E C T I O N -- MYOS RENS Technology Inc./ PR Newswire -6.47%
Apr-20-18 07:20AM  Free Research Report as Lipocine Announced FY17 Financial Results ACCESSWIRE
Apr-12-18 10:00AM  MYOS: A New Product For Sports Nutrition Zacks Small Cap Research
Apr-10-18 09:11AM  Was MYOS RENS Technology Incs (NASDAQ:MYOS) Earnings Growth Better Than The Industrys? Simply Wall St.
06:10AM  MYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked, and Earns Prestigious "Certified For Sport®" Certification From NSF International PR Newswire
Apr-06-18 07:55AM  Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJ's Restaurants What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-03-18 03:15PM  MYOS: Initiation Report Zacks Small Cap Research +8.06%
02:54PM  MYOS RENS Technology to Present at the MicroCap Conference April 10 in New York City at the Essex House PR Newswire
Mar-28-18 01:53PM  MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017 PR Newswire
08:00AM  MYOS RENS Technology Inc. to Host Earnings Call ACCESSWIRE
Mar-27-18 05:48PM  MYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial Results PR Newswire
06:10AM  MYOS RENS Technology, Inc. Announces Research Agreement with Rutgers University Focused on Discovery of Compounds and Products for Improving Muscle Health and Performance PR Newswire
Mar-20-18 04:19PM  MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Year Ended December 31, 2017 Results, Conference Call and Webcast PR Newswire
Mar-05-18 07:35AM  Detailed Research: Economic Perspectives on Lear, MYOS RENS Technology, Dollar Tree, Halliburton, Waters, and ANI Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-15-18 06:05AM  MYOS RENS Technology to Showcase Fortetropin® and the Qurr® Line of Muscle Health Products at the 2018 Arnold Sports Festival in Columbus, OH from March 2-4, 2018 PR Newswire
Jan-16-18 06:05AM  MYOS RENS Technology Launches 30-Day Qurr® Fortetropin® Challenge PR Newswire
Jan-11-18 06:05AM  MYOS RENS Technology CEO Issues Shareholder Letter PR Newswire
Dec-06-17 06:05AM  MYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And Women PR Newswire
Nov-14-17 06:10AM  MYOS RENS Technology Reports Third Quarter 2017 Financial Results PR Newswire +14.67%
Nov-08-17 06:05AM  MYOS RENS Technology Inc. Launches Collegiate Sports Marketing Platform PR Newswire
Nov-03-17 02:59PM  Who Really Owns MYOS RENS Technology Inc (MYOS)? Simply Wall St. -6.35%
Oct-26-17 06:10AM  Pro Football Legends, the Commercial Marketing Arm of the NFL Alumni, Launches Partnership with MYOS RENS Technology Inc. in Optimal Bowl and Wellness Challenge PR Newswire -5.37%
Sep-20-17 09:03AM  MYOS RENS Technology Inc. Appoints Joseph Mannello as Permanent Chief Executive Officer PR Newswire -8.81%
Aug-24-17 11:28AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Jul-12-17 06:12AM  MYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las Vegas PR Newswire
Jun-02-17 09:54AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Apr-24-17 06:05AM  MYOS RENS Will Be Silver Sponsor at International Conference on Frailty and Sarcopenia Research (ICFSR) PR Newswire
Apr-18-17 06:05AM  MYOS RENS enters into agreement with Kansas State University to study impact of Fortetropin® on reducing muscle loss in dogs after joint surgery PR Newswire
Apr-06-17 12:05PM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q4, 2016 By the Numbers : April 6, 2017 Capital Cube
09:54AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: 2016 By the Numbers : April 6, 2017 Capital Cube
Mar-31-17 06:11AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report
06:01AM  MYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launch PR Newswire
Mar-13-17 06:00AM  Are you Qurr-ious? MYOS Rens Technology Inc. Launches Qurr Product Line Powered by Fortetropin®, an All-Natural Ingredient Clinically Proven to Increase Muscle Size and Mass PR Newswire
Mar-01-17 03:26PM  'Qurr' line of revolutionary muscle-health and muscle-building products in newly-enhanced form set for March rollout Marketwired
Feb-21-17 08:36AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
Feb-14-17 06:13PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Ri
06:00PM  MYOS RENS Technology Inc. Adopts Shareholder Rights Plan Marketwired
Feb-07-17 05:05PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, F
Feb-06-17 09:30AM  Key Catalyst That Could Send Biotechs Soaring in 2017: Today's Reports on MYOS RENS Technology and Actinium Pharmaceuticals Accesswire
Feb-03-17 02:54PM  MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering Marketwired
Jan-30-17 08:00AM  Dr. Robert Hariri, stem cell pioneer and chairman of MYOS RENS Technology, states that 'healthy muscle is key to overall health and wellness' Marketwired
Jan-23-17 04:43PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-11-17 04:46PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other
Dec-22-16 04:31PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-25-16 08:01AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-22-16 01:04PM  MYOS RENS TECHNOLOGY INC. Financials
Nov-18-16 11:46AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Capital Cube
Nov-14-16 04:13PM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report
Sep-29-16 08:00AM  MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript Marketwired
Sep-07-16 12:32PM  MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer Marketwired
MYOS RENS Technology Inc. focuses on the discovery, development, and commercialization of nutritional and therapeutic products that enhance muscle health and performance. The company primarily focuses on developing products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity. Its products include Qurr line of products comprising flavored puddings, powders, and shakes; Yolked line of products for collegiate and professional athletes; and Myos Canine Muscle Formula line of products for pets. The company sells its products through direct-to-consumer e-commerce platform; and at the Vitamin Shoppe. MYOS RENS Technology Inc. has a research agreement with the University of California to study the effects Of Fortetropin on skeletal muscle protein synthetic rate in older men and women; Rutgers University for the discovery development and commercialization of products that improve muscle health and performance; and Weill Cornell Medical College to study the efficacy of Fortetropin in preventing weight and muscle loss associated with cancer. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PECHOCK CHRISTOPHERDirectorMar 27Buy1.4634,24750,001257,157Mar 27 07:07 PM
Mannello JosephChief Executive OfficerMar 27Buy1.46171,233250,000689,210Mar 27 07:06 PM